Vol 2 | Issue 6 | January 2020
Make sure you get all our latest updates by subscribing today. Have something to share in the newsletter? Drop us an email at cancercenter@gwu.edu .
The Cutaneous Oncology Program at the GW Cancer Center will serve as the first global site for a phase II clinical trial in neoadjuvant immunotherapy for high risk cutaneous squamous cell carcinoma, one of the most common forms of skin cancer.
Thousands of Washington, D.C. residents streamed through the Walter E. Washington Convention Center to take part in the annual NBC4 Health and Fitness Expo. Members of the GW Cancer Center provided cancer screenings and prevention information.
The GW Cancer Center recently released a RFA for targeted pilot awards that directly advance the scientific themes of the Population Sciences and Policy Program. Applications are due March 13. Members of the Pop Sci program are eligible to apply.
Beverly Long, MD
Beverly Long, MD, is an accomplished surgeon and assistant professor of obstetrics and gynecology at the GW School of Medicine and Health Sciences. Her expertise includes administration of chemotherapy, targeted therapies and immunotherapy for gynecologic cancers. Her clinical interests include complex ovarian cancer surgery, robotic surgery and extramammary Paget’s disease. Learn more about Dr. Long and what inspires her most about her work.
WHAT WE'RE READING
The latest cancer news
UPCOMING EVENTS
Mark your calendars
RECENT MEMBER AWARDS
Sara Rosenbaum, PhD: Field Work and Analysis of Community Health Center Data (Henry J. Kaiser Family Foundation)

Amanda J. Visek, PhD: Swedish Translation of FUN MAPS (Swedish Ice Hockey Federation)

Ami Zota, ScD, MS: The Impact of Housing Assistance on Residential Environmental Exposures (U.S. Department of Housing and Urban Development)
FUNDING OPPORTUNITIES
GW: New Venture Competition (due 2/5)


GW Cancer Center/Katzen Pilot Award Program: Population Sciences and Policy Program Enhancement (due 3/13)

Looking for additional funding opportunities and announcements? Check out the latest Funding Flash or Research Matters .